Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis-Reference-Cited by-同舟云学术

Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis

Published:2017-12-18 Issue:4 Volume:37 Page:901-908
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Barbosa-Cobos Rosa Elda,Lugo-Zamudio Gustavo,Flores-Estrada Javier,Becerril-Mendoza Lizbeth Teresa,Rodríguez-Henríquez Pedro,Torres-González Rubén,Moreno-Eutimio Mario Adán,Ramirez-Bello Julian,Moreno José

Funder

Hospital Juárez de México

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-017-3929-6/fulltext.html

Reference37 articles.

1. Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64(5):640–647. https://doi.org/10.1002/acr.21649

2. Backhaus M, Ohrndorf S, Kellner H, Strunk J, Backhaus TM, Hartung W, Sattler H, Albrecht K, Kaufmann J, Becker K, Sorensen H, Meier L, Burmester GR, Schmidt WA (2009) Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthritis Rheum 61(9):1194–1201. https://doi.org/10.1002/art.24646

3. Bakker MF, Cavet G, Jacobs JW, Bijlsma JW, Haney DJ, Shen Y, Hesterberg LK, Smith DR, Centola M, van Roon JA, Lafeber FP, Welsing PM (2012) Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Ann Rheum Dis 71(10):1692–1697. https://doi.org/10.1136/annrheumdis-2011-200963

4. Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR (2013) Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One 8(4):e60635. https://doi.org/10.1371/journal.pone.0060635

5. Colebatch AN, Edwards CJ, Ostergaard M, van der Heijde D, Balint PV, D'Agostino MA, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik AG, Landewe RB, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 72(6):804–814. https://doi.org/10.1136/annrheumdis-2012-203158

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha Calcitonin Gene-related Peptide, Neuropeptide Y, and Substance P as Biomarkers for Diagnosis and Disease Activity and Severity in Multiple Sclerosis;CNS & Neurological Disorders - Drug Targets;2024-04

2. Antagonism of Tachykinin receptor 1 promotes Foxp3+ regulatory CD4 T cells and controls gut mucosal inflammation;2024-03-28

3. Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care;Clinical and Experimental Medicine;2024-01-31

4. Serum substance P level as a marker for subclinical rheumatoid arthritis activity;Egyptian Journal of Basic and Applied Sciences;2023-04-28

5. Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders;International Journal of Molecular Sciences;2022-02-26